← Company intelligence

Robot maker · early

Conceivable Life Sciences

Corporate marketmedicallabCurated record

Developing AURA, described as the world's first AI-powered automated IVF lab: AI-driven algorithms direct robotic hardware to perform high-precision steps across the entire IVF workflow, from sperm selection and ICSI micromanipulation to embryo handling. Founded 2022 in New York by Joshua Abram, Alan Murray and reproductive endocrinologist Dr. Alejandro Chavez-Badiola; raising to launch the automated lab commercially in the US.

HeadquartersNew York, US
Founded2022
Corporate funding$105M
Team51-200
Deployments0
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries A ($18M Jan 2025 led by ARTIS Ventures; $50M extension Sep 2025 led by AVP; ~$70M total)
FoundersJoshua Abram (Co-founder), Alan Murray (Co-founder), Alejandro Chavez-Badiola (Co-founder & CMO)
Regions servedNorth America, Latin America
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinelab

AURA automated IVF lab

  • AI-driven algorithms applied to robotic hardware for high-precision automation across the entire IVF lab workflow — billed as the world's first automated IVF lab

    vendor-stated automated laboratory robotics platform

    Claim source
CA

Funding history

Publicly announced rounds

Investors on recordARTIS VenturesAdvance Venture PartnersStrideACMEMuse CapitalAtlantic Health Venture Studio
TL

Company timeline

Milestones and announcements

2025-09-15Secured $50M Series A extension led by Advance Venture Partners for US launch of the automated IVF lab (~$70M total)BioSpace
2025-01-14Closed $18M Series A led by ARTIS Ventures to advance the AURA automated IVF labBioSpace
SC

Source ledger

3 unique public sources

Record / conceivable-life-sciencesLast reviewed / 2026-07-053 sourcesMachine-readable